Iconovo AB ICO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 0.97
- Day Range
- SEK 0.93–0.98
- 52-Week Range
- SEK 0.87–2.02
- Bid/Ask
- SEK 0.93 / SEK 0.98
- Shares Outstanding
- 96.17M
- Market Cap
- SEK 94.06M
- Volume/Avg
- 11,000 / 66,721
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 40.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.iconovo.se
Valuation
|
Metric
|
ICO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.63 |
Price/Sales | 40.37 |
Price/Cash Flow | — |
Price/Earnings
ICO
Financial Strength
|
Metric
|
ICO
|
|---|---|
Quick Ratio | 3.06 |
Current Ratio | 3.06 |
Interest Coverage | −103.66 |
Quick Ratio
ICO
Profitability
|
Metric
|
ICO
|
|---|---|
Return on Assets (Normalized) | −25.67% |
Return on Equity (Normalized) | −28.27% |
Return on Invested Capital (Normalized) | −27.14% |
Return on Assets
ICO
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|zdRkNXs | LOCK|w>PCw | $177B | |||
| Medtronic PLC
MDT
| LOCK|KgZ#Zls | LOCK|$x?r | $121B | |||
| Stryker Corp
SYK
| LOCK|&!<DLZk | LOCK|T@ | $117B | |||
| Boston Scientific Corp
BSX
| LOCK|r>G^MW | LOCK|rTW$ | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|>>^%^#!@ | LOCK|PZ<?@ | $51B | |||
| DexCom Inc
DXCM
| LOCK|#<<^SRB | LOCK|kR$#@ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|c$k%P%j | LOCK|M& | $32B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|%?Q | LOCK|tN | $25B | |||
| Steris PLC
STE
| LOCK|WVF><?v | LOCK|v!Cs& | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|CnX>tl&x | LOCK|hr | $18B |
United States